Encompass Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Encompass Health (EHC).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

10Buy

Consensus RatingBuy# Analysts11Avg. Consensus PT$131Upside to Avg. PT-1.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	Keybanc	Matthew Gillmor	PT Raise	Overweight	$147→$150
Oct 29, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$144→$151
Aug 10, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$125→$140
Aug 7, 2026	UBS	A.J. Rice	PT Raise	Buy	$150→$155
Aug 7, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$140→$150
Aug 6, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$140→$144
May 28, 2026	TD Cowen	Ryan Langston	Initiate	Buy	$125
May 5, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$153→$140
Feb 6, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$150→$153
Oct 30, 2025	Barclays	Andrew Mok	PT Raise	Overweight	$141→$150
Oct 2, 2025	UBS	A.J. Rice	PT Raise	Buy	$140→$150
Sep 16, 2025	Keybanc	Matthew Gillmor	PT Raise	Overweight	$135→$140
Sep 10, 2025	B of A Securities	Kevin Fischbeck	PT Raise	Buy	$145→$160
Aug 14, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$135→$140
Aug 6, 2025	UBS	Andrew Mok	PT Raise	Buy	$130→$140
Jun 5, 2025	Stephens & Co.	Raj Kumar	Maintained	Overweight	$135
May 27, 2025	Keybanc	Matthew Gillmor	PT Raise	Overweight	$122→$135
Apr 28, 2025	UBS	Andrew Mok	PT Raise	Buy	$117→$130
Apr 28, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$110→$125
Apr 28, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$116→$135

Analyst Ratings News

PRO
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150

Keybanc analyst Matthew Gillmor maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $147 to $150.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $144 to $151.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.

Benzinga Newsdesk

Encompass Health Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Encompass Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

People Also Watch

People Also Watch

Encompass Health Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Encompass Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROKeybanc Maintains Overweight on Encompass Health, Raises Price Target to $150

PROBarclays Maintains Overweight on Encompass Health, Raises Price Target to $151

PROTD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PROUBS Maintains Buy on Encompass Health, Raises Price Target to $155

PROTruist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PROBarclays Maintains Overweight on Encompass Health, Raises Price Target to $144

People Also Watch

People Also Watch

PRO
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144